Press release
Uterine Fibroids Treatment Market Size, Share, Trends, Industry Analysis And Global Forecast 2023-2032 | Gynesonics Inc., Medtronic Plc., Boston Scientific Corporation, Karl Storz Gmbh, Pfizer Inc.
Uterine Fibroids Treatment Market Report
The Business Research Company's Uterine Fibroids Treatment Global Market Report 2023 identifies the high prevalence of uterine fibroids among women worldwide as the major driver for the uterine fibroids treatment market's growth in the forecast period. Uterine fibroids refer to non-cancerous growths that develop in the uterus and can cause symptoms such as heavy pelvic pain, and pressure on the bladder or bowel. Uterine fibroids treatment treats fibroids by blocking the production of estrogen and progesterone and improving anemia.
The global uterine fibroids treatment market size is expected to grow from $3.33 billion in 2022 to $3.67 billion in 2023 at a compound annual growth rate (CAGR) of 10.4%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global uterine fibroids treatment market size is expected to reach $5.26 billion in 2027 at a CAGR of 9.4%.
Download Free Sample Of Uterine Fibroids Treatment Market Report -
https://www.thebusinessresearchcompany.com/sample_request?id=10766&type=smp
Major competitors in the uterine fibroids treatment market are Gynesonics Inc., Medtronic Plc., Boston Scientific Corporation, Karl Storz Gmbh, Pfizer Inc.,
A key trend in the uterine fibroids treatment market includes product innovations. Companies operating in the uterine fibroid treatment market are adopting innovative products to sustain their position in the market. For instance, in May 2021, Myovant Sciences, a Switzerland-based healthcare company, and Pfizer, a US-based multinational pharmaceutical and biotechnology corporation, received FDA approval for MYFEMBREE® (relugolix 40 mg, estradiol 1 mg, and norethindrone acetate 0.5 mg). This is the first once-daily treatment with a maximum 24-month treatment duration for the control of severe monthly bleeding brought on by uterine fibroids in premenopausal women.
Read More On The Global Uterine Fibroids Treatment Market Report Here:
https://www.thebusinessresearchcompany.com/report/uterine-fibroids-treatment-global-market-report
The uterine fibroids treatment market is segmented -
•By Type: Subserosal Fibroids, Intramural Fibroids, Submucosal Fibroids, Pedunculated Fibroids
•By Treatment Type: Hormone Therapy, Androgens, Gonadotropin-Releasing Hormone Antagonists, Uterine Artery Embolization, Myomectomy, Hysterectomy
•By End-Users: Hospitals, Ambulatory Surgical Centers, Other End users.
•By Geography: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. North America was the largest region in the uterine fibroids treatment market.
The Business Research Company's "Global Uterine Fibroids Treatment Market Report 2023" provides a thorough understanding of the market across 60 geographies. The report covers market size, growth rate, segments, drivers and trends in every region and country. In addition, the report offers insights on historical and forecast growth, helping players analyze and strategize better.
Explore Buying Options For The Uterine Fibroids Treatment Market Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10766
The Table Of Content For The Uterine Fibroids Treatment Market Include:
1. Executive Summary
2. Uterine Fibroids Treatment Market Characteristics
3. Uterine Fibroids Treatment Market Trends And Strategies
4. Uterine Fibroids Treatment Market - Macro Economic Scenario
5. Uterine Fibroids Treatment Market Size And Growth
……
26. Africa Uterine Fibroids Treatment Market
27. Uterine Fibroids Treatment Market Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions In The Uterine Fibroids Treatment Market
29. Uterine Fibroids Treatment Market Future Outlook and Potential Analysis
30. Appendix
Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx
Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.
Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Uterine Fibroids Treatment Market Size, Share, Trends, Industry Analysis And Global Forecast 2023-2032 | Gynesonics Inc., Medtronic Plc., Boston Scientific Corporation, Karl Storz Gmbh, Pfizer Inc. here
News-ID: 3304059 • Views: …
More Releases from The Business Research Company
Trends in Growth, Segment Analysis, and Competitive Strategies Influencing the M …
The meal replacement market is gaining significant momentum as consumer preferences shift toward convenient and health-focused nutrition solutions. With rising awareness about preventive healthcare and personalized diets, this sector is set for considerable expansion. Let's explore how the market size is expected to evolve, who the key players are, emerging trends, and the main segments driving this growth.
Projected Growth Trajectory of the Meal Replacement Market Size
The meal replacement…
Leading Companies Reinforcing Their Presence in the Malted Barley Market
The malted barley industry is positioned for steady expansion as demand grows across various sectors. With increasing interest from craft brewers and functional food producers, this market is set to experience meaningful growth driven by innovation and sustainability efforts. Let's dive into the current market size, key players shaping the industry, trends influencing its trajectory, and detailed segment insights.
Projected Market Size and Growth Outlook of the Malted Barley Market …
Future Perspective: Key Trends Shaping the Low-calorie Food Market up to 2030
The low-calorie food market is poised for significant expansion as consumer preferences shift toward healthier eating habits and more personalized nutrition options. Advances in product innovation and supportive regulatory frameworks are expected to drive rapid growth over the coming years. Here's an overview of the market size, key players, emerging trends, and segmentation shaping this evolving industry.
Projected Expansion of the Low-calorie Food Market Size Through 2030
The low-calorie food…
Competitive Landscape: Leading Companies and New Entrants in the Liquid Nutritio …
The liquid nutritional supplement sector is on the rise, driven by evolving consumer preferences and innovations in health and wellness. With growing awareness about personalized nutrition and preventive healthcare, this market is set to witness substantial growth over the coming years. Let's explore the market's projected size, major players, emerging trends, and key segments shaping this dynamic industry.
Projected Market Value and Growth Trajectory of the Liquid Nutritional Supplement Market …
More Releases for Fibroids
Global Uterine Fibroids Market Research Report 2023
Uterine fibroids (myoma) are benign (non-cancerous) lumps that grow in the muscular wall of the uterus. They vary in sizes, from minute (a quarter of an inch) to the size of more than16 centimeters. The incidence of uterine fibroid is about 20%-40% in women during their reproductive ages. Occasionally, these fibroids swell up and make the uterus to grow like full visible pregnancy. Mostly, there are more than one fibroid…
Uterine Fibroids Symptoms
USA Fibroids Center is here to offer detailed information on https://www.usafibroidcenters.com/blog/uterine-fibroids-symptoms/ and help you discuss the best treatments for uterine fibroids at the clinic.
Find out the best Fibroid Treatment for you!
Treatments for uterine fibroids are accessed in women with problems related to them and show symptoms such as heavy menstrual bleeding, pain or pressure in the pelvis, or infertility and sterility.
…
Uterine Fibroids - Drug Pipeline Landscape, 2022 | Global Insight Services
Uterine fibroids are a common type of noncancerous tumor that can grow in and on your uterus. Uterine fibroids are found incidentally during a routine pelvic exam. The causes of fibroids are unknown. Most fibroids happen in people of reproductive age. Possible causes include genetic changes, hormones, other growth factors and extracellular matrix.
Uterine fibroids patients may have symptoms, including excessive or painful m*nstruation, bloating, frequent urination, pain during intercourse, low…
Uterine Fibroids Market 2022 | Detailed Report
The research reports on "Uterine Fibroids Market" report gives detailed overview of factors that affect global business scope. Uterine Fibroids Market report shows the latest market insights with upcoming trends and breakdowns of products and services. This report provides statistics on the market situation, size, regions and growth factors. An exclusive data offered in this report is collected by research and industry experts team.
Download FREE Sample Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5396435
The…
Uterine Fibroids Treatment Market: Rising Prevalence of Uterine Fibroids amongst …
The high prevalence of uterine fibroids across the U.S. has created a significant demand for uterine fibroid treatments across the countries. The growing public concern about the occurrence of uterine fibroids, which are also called uterine leiomyoma, have propelled the demand for treatments and solutions to alleviate the pain, excessive bleeding, and pelvic discomfort.
According to the report by Transparency Market Research, the U.S. uterine fibroid treatment market is anticipated to…
Uterine Fibroids Treatment Market: Trends, Opportunities and Forecasts 2024
U.S. Uterine Fibroids Market: Snapshot
The uterine fibroid treatment market is driven by growing number of hysterectomy surgeries every year in the country. Furthermore, the rising coverage of healthcare and increasing prevalence of non-cancerous tumors in women of childbearing age is expected to be the most vital reason for expansion of the uterine fibroids market growth. Now a days, fibroids are an important public health concern, due of the large number…
